The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

PEP, 2 or better 3 drugs?
Nov 23, 2013

Hello Dr. Young,

I had a risk contact and started a PEP approx. 46h after. The doctor gave me Combid 300mg lamivudine zidovudine for 2 times a day (4 weeks).

After checking internet a little further I noticed other people take a third drug in addition + Stocrin 600mg.

Does it make a big difference taking only combid300? Should I better get Stocrin too or is it too late 6 days after start?

Thank you very much in advance!

Response from Dr. Young

Hello and thanks for posting.

There is difference in opinion about whether 2 or 3 drugs is optimal for post exposure prophylaxis, and here in the US, efavirenz (Stocrin/Sustiva) isn't generally recommended for this purpose. This is because of two major reasons: first, efavirenz side effects can be particularly bothersome for people taking PEP, and secondly, efavirenz resistance appears in about 5-10% of transmitted viruses-- limiting the potential benefit.

Either way, it's probably past the time when adding efavirenz would make a substantial difference, so I'd just continue onward with the AZT+3TC that you're taking.

Be well, BY

Treatment Naive with Resistance
just started meds and got the flu

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint